NPNT被鉴定为IGF1作用的新靶点
该研究基于Laron综合征(LS)患者癌症保护现象,发现NPNT是LS细胞中下调最显著的基因(p=0.0148,倍数变化-3.12)。实验表明IGF1刺激LS淋巴母细胞及乳腺癌、前列腺癌细胞中NPNT表达,且NPNT沉默可减弱AKT和ERK1/2通路活化并抑制细胞增殖。结论提示NPNT是IGF1作用的新靶点,其与IGF1通路的交互作用值得进一步研究。
要点
- LS患者来源细胞中NPNT表达显著下调,与癌症保护相关。
- IGF1可刺激LS淋巴母细胞及多种癌细胞系中NPNT表达。
- NPNT沉默减弱AKT和ERK1/2通路活化并降低细胞增殖。
核心结论
- NPNT基因是IGF1作用的新靶点,其功能与物理交互的临床意义值得进一步研究。
研究设计与样本
- 研究在LS淋巴母细胞系及人乳腺癌和前列腺癌细胞中评估基础和IGF1刺激的NPNT表达,并使用siRNA进行NPNT沉默实验。
主要发现
- NPNT是LS来源细胞中下调最显著的基因(p=0.0148;倍数变化-3.12 vs 对照)。
- IGF1刺激LS淋巴母细胞和多种癌细胞系中NPNT表达。
- NPNT沉默导致AKT和ERK1/2通路活化减弱,并伴随细胞增殖下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The growth hormone (GH)-insulin-like growth factor-1 (IGF1) endocrine axis has a key role in normal growth and development. Laron syndrome (LS) is a type of dwarfism that results from mutation of the GH receptor, leading to congenital IGF1 deficiency. Epidemiological studies have shown that LS patients are protected from cancer. Genome-wide profiling led to the identification of a series of metabolic genes whose differential expression in LS might be linked to cancer protection. Nephronectin (NPNT) is an intracellular and secreted extracellular matrix protein with important roles in kidney development. NPNT was identified as the top-downregulated gene in LS-derived cells in comparison with ethnic-, age- and gender-matched controls (p-value = 0.0148; fold-change = -3.12 versus controls). NPNT has not been previously linked to the IGF1 signaling pathway. The present study was aimed at evaluating the hypothesis that NPNT is a new target for IGF1 action and that decreased expression of NPNT in LS is correlated with cancer protection. METHODS: Basal and IGF1-stimulated NPNT expression were assessed in LS lymphoblastoid cells as well as in human breast and prostate cancer cells. NPNT silencing experiments were conducted using siRNA methodology. RESULTS: We provide evidence that IGF1 stimulates NPNT expression in LS-derived lymphoblastoids and various cancer cell lines. In addition, we demonstrate that NPNT silencing results in diminished activation of the AKT and ERK1/2 pathways, with ensuing decreases in cellular proliferation. CONCLUSIONS: Our data identified the NPNT gene as a target for IGF1 action. The clinical implications of the functional and physical interactions between NPNT and the IGF1 pathway merit further investigation.
引用
- Sarfstein R, Lapkina-Gendler L, Nagaraj K, et al. Identification of nephronectin as a new target for IGF1 action. Eur J Cancer. 2020. PMID: 33130549. doi:10.1016/j.ejca.2020.09.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。